Articles Posted in Mass Torts

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

Our lawyers are handling baby powder lawsuits in all 50 states in 2026. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women.

This page provides an update on J&J talc powder litigation and discusses the settlement amounts in ovarian cancer lawsuits for victims.

Has the deadline passed for you to file a talcum powder lawsuit? Many who assume the statute of limitations has passed to sue Johnson & Johnson may be wrong. But as we write this in January 2026, his settlement has blown up, and we are back at it. We are still signing up new clients, but this may not last much longer. Call us today at 800-553-8082 or get a free and quick case review online.

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading

This page examines Suboxone, its associated dental complications, and the subsequent Suboxone tooth decay lawsuits that occurred in 2025. 

What is the Suboxone lawsuit about? The lawsuit is about what Suboxone does to your teeth. The core of every Suboxone lawsuit is that the defendants knew of the risk of severe tooth decay and other dental injuries. They did not convey that risk to prescribing doctors or patients because they chose profits over people.

Unfortunately, our lawyers are no longer taking on new Suboxone cases in 2026.  

Continue reading

Thousands of women who underwent internal bra breast surgery are now experiencing serious complications from the surgical mesh placed inside them, and many are pursuing legal action against the manufacturers that promoted these products for a use the FDA never approved.

Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, and AlloMax marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those applications had never been adequately studied or approved by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, and the need for additional surgery, most women did not have the information to connect the dots from their problems to the problems with the devices.

This page explains the internal bra mesh lawsuit in plain English: what the legal claims are, who may be eligible, what complications may qualify, and what these cases may be worth.

Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.

Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.

Continue reading

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

In many cases our lawyers are now investigating, patients who received Dupixent for newly diagnosed eczema and developed concerning symptoms within weeks or months, including swollen lymph nodes and worsening skin disease.

Our attorneys also provide the latest updates on the Zantac class action lawsuit (including the disastrous news that the class action judge dismissed all federal court Zantac lawsuits). This page was updated on April 21, 2026.

Zantac Cancer Lawsuit Updates 2026

The Zantac litigation has been a rollercoaster, filled with major victories, setbacks, and unexpected twists. From the initial discovery of NDMA contamination to the collapse of certain cases and the resurgence of others, this litigation has taken many turns.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died. The infections were caused by drug-resistant bacteria that no antibiotic could reliably kill. The patients had gone into the hospital for routine diagnostic procedures–gallstone evaluations, pancreatic biopsies, bile duct imaging–and came out with infections that would destroy their organs, land them in intensive care for months, or kill them outright.

The remarkable part is not that it happened. Medical devices fail. Infections occur. What makes the Olympus duodenoscope litigation extraordinary is that the company knew. Olympus knew its scopes could not be adequately cleaned. Olympus knew that bacteria were surviving the sterilization process and spreading from patient to patient. Olympus knew that people were dying. And for years, the company did almost nothing.

This page explains what went wrong, why it went wrong, and the legal options available to patients and families harmed by contaminated Olympus scopes. It is long. It is detailed. It is written for people who want to understand not just the claims being filed, but the science, the regulatory failures, and the corporate decisions that turned a solvable engineering problem into a public health catastrophe.

Contact Information